期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Unraveling the epidemiology of metabolic dysfunction-associated liver cancer:Insights from mixed etiologies,regional variations,and gender disparities
1
作者 Gong Feng Ya-Fei Fan +3 位作者 Ru-Xin Li Giovanni Targher Christopher D.Byrne Ming-Hua Zheng 《iLIVER》 2024年第3期57-58,共2页
The Korean Republic nationwide cohort study by Yun et al.reveals a stepwise increase in hepatocellular carcinoma(HCC)risk,progressing from“pure”metabolic dysfunction-associated steatotic liver disease(MASLD)to MASLD... The Korean Republic nationwide cohort study by Yun et al.reveals a stepwise increase in hepatocellular carcinoma(HCC)risk,progressing from“pure”metabolic dysfunction-associated steatotic liver disease(MASLD)to MASLD with increased alcohol intake(MetALD)and then to alcohol-associated liver disease[1].These data also highlight the significant impact of age and gender,underscoring the importance of tailoring prevention strategies to address not only metabolic dysfunction but also alcohol consumption in liver disease management[1].This Korean cohort study also illustrates the characteristics of MASLD-related HCC,providing new insights into the natural history of this liver disease. 展开更多
关键词 EPIDEMIOLOGY prevention GENDER
原文传递
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma:present and future 被引量:2
2
作者 Feng Gao Gang Chen +3 位作者 Christopher D.Byrne Giovanni Targher Tan To Cheung Ming-Hua Zheng 《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第6期945-948,共4页
Metabolic dysfunction-associated fatty liver disease(MAFLD),previously termed non-alcoholic fatty liver disease,is one of the most common causes of chronic liver disease,affecting around 30%of the world’s adults(1).M... Metabolic dysfunction-associated fatty liver disease(MAFLD),previously termed non-alcoholic fatty liver disease,is one of the most common causes of chronic liver disease,affecting around 30%of the world’s adults(1).MAFLD encompasses a spectrum of liver conditions,ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis(MASH),which can progress to cirrhosis and hepatocellular carcinoma(HCC)(2,3). 展开更多
关键词 Metabolic dysfunction-associated fatty liver disease(MAFLD) metabolic dysfunction-associated steatotic liver disease nonalcoholic fatty liver disease hepatocellular carcinoma(HCC) EPIDEMIOLOGY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部